Gland Pharma Ltd. - Research Center
543245 GLAND Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | ||
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 2,633.24 | 2,044.20 | 1,619.94 | 1,479.18 | |
| Expenses | |||||
| Material consumed | 1,136.27 | 883.30 | 681.41 | 528.72 | |
| Manufacturing expenses | 78.50 | 74.03 | 60.35 | 49.24 | |
| Personnel expenses | 277.66 | 222.95 | 179.08 | 153.42 | |
| Selling expenses | 5.19 | 4.21 | 2.01 | 2.05 | |
| Adminstrative expenses | 180.15 | 153.41 | 161.98 | 120.76 | |
| Expenses capitalised | - | - | - | - | |
| Cost of sales | 1,677.77 | 1,337.89 | 1,084.84 | 854.19 | |
| Operating profit | 955.47 | 706.31 | 535.11 | 624.99 | |
| Other recurring income | 139.17 | 85.56 | 48.79 | 33.56 | |
| Adjusted PBDIT | 1,094.64 | 791.88 | 583.89 | 658.55 | |
| Financial expenses | 7.18 | 3.56 | 4.13 | 6.39 | |
| Depreciation | 94.59 | 81.96 | 78.21 | 74.15 | |
| Other write offs | - | - | - | - | |
| Adjusted PBT | 992.87 | 706.36 | 501.56 | 578.01 | |
| Tax charges | 220.01 | 234.45 | 180.45 | 164.29 | |
| Adjusted PAT | 772.86 | 471.91 | 321.11 | 413.73 | |
| Non recurring items | - | -20.00 | - | - | |
| Other non cash adjustments | - | - | - | - | |
| Reported net profit | 772.86 | 451.91 | 321.11 | 413.73 | |
| Earnigs before appropriation | 3,025.72 | 2,252.86 | 1,874.98 | 1,553.86 | |
| Equity dividend | - | - | - | - | |
| Preference dividend | - | - | - | - | |
| Dividend tax | - | - | - | - | |
| Retained earnings | 3,025.72 | 2,252.86 | 1,874.98 | 1,553.86 | |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis